Contribution of PET/CT to Prediction of Outcome in Children and Young Adults with Rhabdomyosarcoma

被引:46
作者
Baum, Sven H.
Fruehwald, Michael [2 ]
Rahbar, Kambiz
Wessling, Johannes [3 ]
Schober, Otmar
Weckesser, Matthias [1 ]
机构
[1] Munster Univ Hosp, Nukl Med Klin & Poliklin, Dept Nucl Med, D-48149 Munster, Germany
[2] Munster Univ Hosp, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany
[3] Munster Univ Hosp, Dept Clin Radiol, D-48149 Munster, Germany
关键词
(18)F-FDG PET/CT; rhabdomyosarcoma; prognosis; risk stratification; POSITRON-EMISSION-TOMOGRAPHY; SOFT-TISSUE SARCOMA; INTERGROUP RHABDOMYOSARCOMA; FDG-PET; ADOLESCENTS; RELAPSE; TRIAL;
D O I
10.2967/jnumed.110.082511
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this retrospective study was to evaluate the role of (18)F-FDG PET or PET/CT in the prediction of patient outcome in children and young adults affected by rhabdomyosarcoma. Methods: Forty-one patients with histology-proven rhabdomyosarcoma who underwent PET or PET/CT were identified (age range, 1-20 y; mean age +/- SD, 9.9 +/- 5.8 y). Tumor maximum standardized uptake value (SUV(max)) and visually rated metabolic activity, as well as the presence of metabolically active lymph nodes and distant metastases, were compared with event-free and overall survival. Multivariate Cox regression analyses were performed to compare the prediction of outcome according to metabolic tumor intensity in relation to established prognostic factors. Results: Kaplan-Meier analyses revealed a significantly shorter overall survival in primary tumors visually rated as highly metabolically active or with a ratio of SUVmax to SUV of the liver above 4.6. In addition, metabolically active lymph node and distant site involvement was indicative of significantly lower survival rates. On multivariate Cox regression analysis, the impact of intensity or SUV(max) of the primary tumor on outcome failed to attain significance, although PET performed better than some of the prognostic factors established in larger patient groups (P = 0.081). Conclusion: (18)F-FDG PET/CT is a valuable tool for initial staging in children affected by rhabdomyosarcoma. (18)F-FDG PET/CT may be an additional predictor of outcome and may be used to refine risk-adapted therapy. PET performed better than some established risk factors. The borderline significance level of primary tumor metabolism in multivariate testing may be an effect of the limited sample size. Further prospective evaluations are warranted.
引用
收藏
页码:1535 / 1540
页数:6
相关论文
共 23 条
[11]   PET for staging in rhabdomyosarcoma:: An evaluation of PET as an adjunct to current staging tools [J].
Klem, Michelle L. ;
Grewal, Ravinder K. ;
Wexler, Leonard H. ;
Schoder, Heiko ;
Meyers, Paul A. ;
Wolden, Suzanne L. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (01) :9-14
[12]   Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography [J].
Lucas, JD ;
O'Doherty, MJ ;
Cronin, BF ;
Marsden, PK ;
Lodge, MA ;
McKee, PH ;
Smith, MA .
BRITISH JOURNAL OF SURGERY, 1999, 86 (04) :550-556
[13]   PET/CT in the evaluation of childhood sarcomas [J].
McCarville, MB ;
Christie, R ;
Daw, NC ;
Spunt, SL ;
Kaste, SC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) :1293-1304
[14]   Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group [J].
Pappo, AS ;
Anderson, JR ;
Crist, WM ;
Wharam, MD ;
Breitfeld, PP ;
Hawkins, D ;
Raney, RB ;
Womer, RB ;
Parham, DM ;
Qualman, SJ ;
Grier, HE .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3487-3493
[15]   Pathologic classification of rhabdomyosarcomas and correlations with molecular studies [J].
Parham, DM .
MODERN PATHOLOGY, 2001, 14 (05) :506-514
[16]   Intergroup Rhabdomyosarcoma Study: Update for pathologists [J].
Qualman, SJ ;
Coffin, CM ;
Newton, WA ;
Hojo, H ;
Triche, TJ ;
Parham, DM ;
Crist, WM .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 1998, 1 (06) :550-561
[17]  
Raney R B, 2001, Sarcoma, V5, P9, DOI 10.1080/13577140120048890
[18]   Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for intergroup rhabdomyosarcoma study V [J].
Raney, RB ;
Anderson, JR ;
Barr, FG ;
Donaldson, SS ;
Pappo, AS ;
Qualman, SJ ;
Wiener, ES ;
Maurer, HM ;
Crist, WM .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (04) :215-220
[19]   Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy [J].
Schuetze, SM ;
Rubin, BP ;
Vernon, C ;
Hawkins, DS ;
Bruckner, JD ;
Conrad, EU ;
Eary, JF .
CANCER, 2005, 103 (02) :339-348
[20]   Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma [J].
Tateishi, Ukihide ;
Hosono, Ako ;
Makimoto, Atsushi ;
Nakamoto, Yuki ;
Kaneta, Tomohiro ;
Fukuda, Hiroshi ;
Murakami, Koji ;
Terauchi, Takashi ;
Suga, Tsuyoshi ;
Inoue, Tomio ;
Kim, Edmund E. .
ANNALS OF NUCLEAR MEDICINE, 2009, 23 (02) :155-161